TITLE
The BET-bromodomain inhibitor OTX015 (MK-8628) exerts in vitro and in vivo anti-tumor activity in triple-negative breast cancer models as single agent and in combination with everolimus

ORGANISM
Homo sapiens

SUMMARY
assess the efficacy of OTX015 (MK-8628) BET inhibitor in vitro and in vivo triple negative breast cancer models

DESIGN
GEP analysis of 2 breast cancer cell lines with and without treatment at different timepoints

PLATFORM
GPL10558 Illumina HumanHT-12 V4.0 expression beadchip

CITATIONS
27935867

